Anna Erickson
Overview
Explore the profile of Anna Erickson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Margolis A, Maes M, Erickson A, Steinke K, Pigarelli D
Am J Pharm Educ
. 2025 Mar;
:101392.
PMID: 40081817
Objective: In 2020, the lecture series for a written clinical inquiry (CI) assignment (i.e., drug information papers) transitioned to a flipped model using asynchronous presentations with pre-class assignments followed by...
2.
Jackson L, Erickson A, Camphausen K, Krauze A
Curr Oncol
. 2025 Jan;
32(1).
PMID: 39851932
Glioblastoma (GBM) is a primary central nervous system malignancy with a median survival of 15-20 months. The presence of both intra- and intertumoral heterogeneity limits understanding of biological mechanisms leading...
3.
Erickson A, Jackson L, Camphausen K, Krauze A
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767713
Despite attempts at improving survival by employing novel therapies, progression in glioma is nearly universal. Precision biomarkers are critical to advancing outcomes; however, biomarkers for glioma are currently unknown. Most...
4.
Gezelle J, Korn S, McDonald J, Gong Z, Erickson A, Huang C, et al.
bioRxiv
. 2025 Jan;
PMID: 39763890
Exoribonuclease-resistant RNAs (xrRNAs) are viral RNA structures that block degradation by cellular 5'-3' exoribonucleases to produce subgenomic viral RNAs during infection. Initially discovered in flaviviruses, xrRNAs have since been identified...
5.
Karim C, Panigrahi A, Pearl R, Sodha N, Beaver T, Pelletier J, et al.
Transfusion
. 2024 Dec;
65(2):344-353.
PMID: 39719927
Background: The clinical significance of natural and treatment-emergent antibodies specific for amustaline/glutathione pathogen-reduced red blood cells (PRRBCs) is not known. Study Design And Methods: A Phase 3, randomized clinical trial...
6.
Erickson A, Ter Horst A, Carlson C, Falk B, Kuo Y
Front Microbiol
. 2024 Aug;
15:1430445.
PMID: 39132135
Carrot motley dwarf (CMD) is a viral disease complex caused by co-infection of the polerovirus carrot red leaf virus with the umbraviruses carrot mottle virus or carrot mottle mimic virus,...
7.
Tao Y, Duce M, Erickson A
Sci Rep
. 2024 Jul;
14(1):17307.
PMID: 39068281
Conventional silicon junction detectors encounter significant carrier recombination within the heavily doped p and n layers, as well as beneath the metal contact regions, creating the so-called "dead layers", especially...
8.
Kurudirek S, Kurudirek M, Erickson A, Hertel N, Sellin P, Tratsiak Y, et al.
Sci Rep
. 2024 Jul;
14(1):15803.
PMID: 38982100
We report the photon (PL), electron (CL) and X-ray (XEL) induced luminescence characteristics of high aspect ratio ultra-long (~ 50 µm) ZnO nanorods (NRs) and discuss the potential for fast...
9.
Kurudirek M, Kurudirek S, Hertel N, Erickson A, Sellin P, Mukhopadhyay S, et al.
Materials (Basel)
. 2023 Oct;
16(20).
PMID: 37895699
ZnO nanoarrays were grown via a low-temperature hydrothermal method. Solutions, each with different additive combinations, were prepared and evaluated. The effects of the additives involved in the growth procedure, i.e.,...
10.
Erickson A, Falk B
Front Microbiol
. 2023 Jul;
14:1223265.
PMID: 37485502
Mixed infections of a plant infecting polerovirus, umbravirus, and/or tombusvirus-like associated RNAs (tlaRNAs) produce unique virus disease complexes that exemplify "helper-dependence" interactions, a type of viral synergism that occurs when...